Plgf−/−eNos−/−mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia
Open Access
- 5 April 2006
- journal article
- fj express
- Published by Wiley in The FASEB Journal
- Vol. 20 (7) , 970-972
- https://doi.org/10.1096/fj.05-4481fje
Abstract
Click on the article title to read more.Keywords
This publication has 38 references indexed in Scilit:
- Placenta growth factor is not required for exercise-induced angiogenesisAngiogenesis, 2004
- Therapeutic angiogenesis in cardiovascular diseaseNature Reviews Drug Discovery, 2003
- Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1Nature Medicine, 2003
- Angiogenesis in health and diseaseNature Medicine, 2003
- Structure and Function of Placental Growth FactorTrends in Cardiovascular Medicine, 2002
- Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1Nature Medicine, 2002
- Angiogenesis TherapyCirculation, 2001
- Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsNature Medicine, 2001
- Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.Journal of Clinical Investigation, 1997
- Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.Journal of Biological Chemistry, 1994